RLMD Competitors & Alternatives
Compare Relmada Therapeutics Inc with similar stocks in the same industry
Biotechnology
RLMD
Main Stock$4.43
Tradestie Score
36
Market Cap
$71.69M
Analyst Upside
+142.7%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$90.59
|
$492.21M | - | 47 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$10.12
|
$468.01M | - | 40 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$10.31
|
$463.20M | - | 43 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$7.60
|
$457.09M | - | 35 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.70
|
$454.29M | - | 51 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$13.51
|
$448.32M | - | 33 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$6.62
|
$422.50M | - | 40 | Compare |
More RLMD Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry